Autoimmune Hepatitis Triggered by Anti-TNF- Therapy [PDF]
Case Reports in Medicine, 2013 Autoimmune hepatitis (AIH) is occasionally triggered by drug treatments. Recently, as biological agents are becoming widely used for autoimmune disorders, there have been a growing number of reports of the development of autoimmune processes related to ...
Satoshi Nakayama
doaj +2 more sources
Development of psoriasis in IBD patients under TNF-antagonist therapy is associated neither with anti-TNF-antagonist antibodies nor trough levels. [PDF]
, 2016 BACKGROUND The cause of anti-TNF-induced psoriasis is still unknown. OBJECTIVE We aimed to evaluate if the appearance of psoriasis under anti-TNF therapy is associated with anti-TNF antibody levels and TNF-antagonist trough levels. METHODS
Protic, Marijana +4 more
core +2 more sources
Regulatory T cells in Crohn's disease following anti‐TNF‐α therapy
JGH Open, 2020 Background and Aim Anti‐tumor necrosis factor alpha (TNF‐α) therapy is an effective therapy for Crohn's disease (CD). We investigated FoxP3+ and CD127− regulatory T cells (Tregs) before and after administration of anti‐TNF‐α therapy in CD.
Toshimi Chiba +6 more
doaj +1 more source
Recommendations for tuberculosis screening before and during treatment with tumour necrosis factor inhibitors [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2009 Patients with an autoimmune disease, such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Crohn's disease, ulcerative colitis, uveitis or psoriasis, and treated with the anti-tumour necrosis factor (TNF) alpha inhibitors are at high
Mandić Dragana +6 more
doaj +1 more source
Scientific Reports, 2023 Biological agents known as anti-tumor necrosis factor (TNF) drugs are frequently utilized in the treatment of inflammatory bowel disease (IBD). In this study, we analyzed the shared processes of pyroptosis in Ulcerative colitis (UC) and Crohn's disease ...
Xin Gao +7 more
doaj +1 more source
Brazilian Journal of Pharmaceutical Sciences, 2023 The aim of this study was to evaluate tumor necrosis factor alpha (TNF-α), interleukin (IL)- 17A/F levels in the serum of ankylosing spondylitis (AS) patients after anti-TNF therapy, in order to understand how these cytokines are involved in this ...
Fernanda Formaggi Lara-Armi +7 more
doaj +1 more source
Response to combination therapy with interferon alfa-2a and ribavirin in chronic hepatitis C according to a TNF-alpha promoter polymorphism [PDF]
, 2003 Background. Tumor necrosis factor-alpha (TNF-alpha) is involved in the pathogenesis of chronic active hepatitis C. Polymorphisms in the promoter region of the TNF-alpha gene can alter the TNF-alpha expression and modify the host immune response.
Konig, A. +8 more
core +1 more source
Biomarkers of response to therapy in Ankylosing Spondylitis [PDF]
, 2013 Ankylosing Spondylitis (AS) is a chronic inflammatory disorder of the spine which leads to progressive spinal fusion and deformity. With improvements in MRI, this condition is now being recognized earlier.
Pathan, Ejaz Mohammed Ishaq
core +1 more source
The Korean Journal of Gastroenterology, 2019 Anti-tumor necrosis factor (anti-TNF) is an effective biological agent for the treatment of moderate-to-severe active ulcerative colitis (UC) refractory to conventional therapy.
Yu Kyung Jun +5 more
doaj +1 more source
Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor Therapy [PDF]
Intestinal Research, 2014 Patients with intractable inflammatory bowel diseases (IBD) are increasingly being treated with anti-tumor necrosis factor (TNF) agents and are at increased risk of developing tuberculosis (TB).
Tae Sun Shim
doaj +1 more source